Shripad Kolhatkar – Genericart Medicine
View Detailed Executive Profile →Professional Overview
- Shripad Kolhatkar founded and serves as the Director of Genericart Medicine, starting in July 2015, with a vision to innovate in the field of medicine.
- Under the leadership of Shripad Kolhatkar, Genericart Medicine has focused on integrating technology and personalized care in healthcare delivery.
- Shripad Kolhatkar previously held the position of Branch Manager at Reliance Nippon Life Insurance, where tenure lasted from February 2011 until June 2015, gaining valuable experience in management and client relations.
- The transition from the insurance sector to medicine reflects a commitment to improving health outcomes and a belief in the transformative power of healthcare.
- Genericart Medicine has implemented various initiatives aimed at enhancing patient engagement and overall satisfaction with healthcare services.
- Challenges faced by Genericart Medicine include navigating the complexities of regulatory compliance and adapting to rapid changes in the healthcare landscape.
- Shripad Kolhatkar's strategic direction has attracted partnerships and collaborations that have bolstered the institute’s research capabilities.
- The achievements of Genericart Medicine include recognition for innovation in patient-centered care and contributions to medical research.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Reliance Nippon Life Insurance | Branch Manager | Feb 2011 – Jun 2015 |
| Genericart Medicine | Founder and Director | Jul 2015 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Genericart Medicine corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Shripad Kolhatkar's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Genericart Medicine's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)